✦ LIBER ✦

A dose-ranging study of the pharmacokinetics and pharmacodynamics of the selective apoptotic antineoplastic drug (SAAND), OSI-461, in patients with advanced cancer, in the fasted and fed state

✍ Scribed by C. L. O’Bryant; C. H. Lieu; S. Leong; R. Boinpally; M. Basche; L. Gore; K. Leonardi; M. K. Schultz; S. Hariharan; L. Chow; S. Diab; A. Gibbs; S. G. Eckhardt

Publisher: Springer
Year: 2008
Tongue: English
Weight: 508 KB
Volume: 63
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-008-0761-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I dose-finding study and a pharmac

Phase I dose-finding study and a pharmacokinetic/pharmacodynamic analysis of the neutropenic response of intravenous diflomotecan in patients with advanced malignant tumours

✍ Iñaki F. Trocòniz; María J. Garrido; Cristina Segura; Josep-María Cendrós; Paola 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 293 KB

A two-part Phase II study of cediranib i

A two-part Phase II study of cediranib in patients with advanced solid tumours: the effect of food on single-dose pharmacokinetics and an evaluation of safety, efficacy and imaging pharmacodynamics

✍ Claire L. Mitchell; J. P. B. O’Connor; C. Roberts; Y. Watson; A. Jackson; S. Che 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 631 KB

A phase I and pharmacokinetic study of O

A phase I and pharmacokinetic study of OSI-7904L, a liposomal thymidylate synthase inhibitor in combination with oxaliplatin in patients with advanced colorectal cancer

✍ A. R. Clamp; P. Schöffski; J. W. Valle; R. H. Wilson; S. Marreaud; A.-S. Govaert 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 315 KB

A phase I clinical and pharmacokinetic s

A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer

✍ R. O’Connor; M. O’Leary; J. Ballot; C. D. Collins; P. Kinsella; D. E. Mager; R. 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 291 KB